Opicapone as Adjunctive Therapy to Levodopa in Chinese Patients with Parkinson’s Disease and Motor Fluctuations: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
Opicapone as Adjunctive Therapy to Levodopa in Chinese Patients with Parkinson’s Disease and Motor Fluctuations: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial. // Parkinsonism & Related Disorders. – URL: https://www.sciencedirect.com/science/article/pii/S1353802026008928?dgcid=rss_sd_all
Opicapone as Adjunctive Therapy to Levodopa in Chinese Patients with Parkinson’s Disease and Motor Fluctuations: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial. Parkinsonism & Related Disorders. https://www.sciencedirect.com/science/article/pii/S1353802026008928?dgcid=rss_sd_all
“Opicapone as Adjunctive Therapy to Levodopa in Chinese Patients with Parkinson’s Disease and Motor Fluctuations: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial.” Parkinsonism & Related Disorders.
@article{article61614,
title = {Opicapone as Adjunctive Therapy to Levodopa in Chinese Patients with Parkinson’s Disease and Motor Fluctuations: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial},
journal = {Parkinsonism \& Related Disorders},
url = {https://www.sciencedirect.com/science/article/pii/S1353802026008928?dgcid=rss_sd_all}
}
npj Aging, Published online: 19 November 2026; doi:10.1038/s41514-026-00570-8 Nicotinamide deficiency in the aqueous humor of patients with glaucoma revealed by LC-MS/MS
npj Aging, Published online: 19 November 2026; doi:10.1038/s41514-026-00566-4 Organ-specific proteomic aging in Chinese adults: 20-year clinical outcomes and metabolomic underpinnings